Skip to main content
Fig. 6 | Arthritis Research & Therapy

Fig. 6

From: “Non-criteria” antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort

Fig. 6

The predictive value of the aPLs in clinical affairs. Outcomes are presented in the form of odds ratios between positivity of the biomarker and the appearance of the APS-related clinical manifestations. The left part of the figure concerns pregnancy morbidities, in which “early pregnancy morbidity” refers to at least one fetal loss before 10 weeks of pregnancy, and “late pregnancy morbidity” refers to at least one stillbirth after 10 weeks of pregnancy or premature delivery before 34 weeks of pregnancy. All the outcomes have been adjusted with sex and age

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us